GlassScriptPhysician profile
Michael P Steinmetz
NPI 1689647422
$168,188.89
in general payments reported to CMS, 2019-2025
11 companies · $13K in 2025
The $13K reported for 2025 was more than what 87% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74K · 2020: $29K · 2021: $4,731 · 2022: $19K · 2023: $19K · 2024: $9,848 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $26K · Travel and Lodging: $6,454 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,500 · Food and Beverage: $2,423 · Royalty Or License: $1,405 · Debt Forgiveness: $1,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $26,043.75 |
| Travel and Lodging | $6,453.80 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,500.00 |
| Food and Beverage | $2,423.15 |
| Royalty Or License | $1,405.04 |
| Debt Forgiveness | $1,047.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $73,723.39 | 2019-2025 | Sable, Xlif, Rise-L . Rise-L A/L |
| Zimmer Biomet Holdings, INC. | $50,695.00 | 2019-2022 | |
| Stryker Corporation | $22,008.16 | 2019-2025 | Cascadia Interbody System, Everest Spinal System, N/A |
| Cerapedics INC. | $8,921.37 | 2021-2023 | I-Factor Peptide Enhanced Bone Graft |
| Medtronic USA, INC. | $5,622.59 | 2019-2020 | |
| Zimvie INC. | $3,747.00 | 2022 | |
| Medtronic, INC. | $1,258.46 | 2022-2025 | Stealthstation S8 Platform, Midas Rex, Mazor X System |
| Djo, LLC | $1,047.60 | 2024 | |
| Premia Spine, LTD. | $1,000.00 | 2020 | |
| Bioventus LLC | $127.21 | 2022-2023 | Bonescalpel |
| Nuvasive, INC. | $38.11 | 2023 | Maxcess, Pcm, Tlif |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Steinmetz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.